市場調查報告書
商品編碼
925337

血栓管理設備市場 - 成長,趨勢,預測(2020∼2025)

Clot Management Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

血栓管理設備的成長的主要推動要素中,包含心血管疾病的盛行率增加,老年人口增加,及血塊管理設備的使用增加導致的意識高漲。根據世界衛生組織(WHO),心血管疾病在全世界每年引起1790萬人死亡。再加上中風和心臟病發作的盛行率增加,對血栓治療的微創治療的需求增加,預計推動市場成長。

再加上血栓管理技術的進步和企業努力推動血栓管理用治療方法,更加加速市場成長。但,嚴格法規政策與替代治療的可用性,預計妨礙市場成長。

本報告提供血栓管理設備市場調查,市場概要,各市場成長要素及阻礙因素分析,各產品、各終端用戶、各地區的市場規模的變化與預測,競爭情形,主要企業的簡介,市場機會等全面性資訊。

目錄<

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 市場概要
  • 市場成長要素
    • 心血管疾病和高齡化人口增加的盛行率
    • 對微創手術和科技進步的需求高漲
  • 市場阻礙因素
    • 嚴格的法規手續
    • 替代治療的可用性
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 競爭加劇

第5章 市場細分化

  • 各產品
    • 栓塞切除球囊導管
    • 導管指示血栓溶解設備
    • 經皮血栓切除設備
    • 下腔靜脈濾器
    • 神經血管栓塞術設備
  • 各終端用戶
    • 醫院
    • 門診病人手術中心
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲地區
    • 南美

第6章 競爭情形

  • 企業簡介
    • Medtronic Plc
    • Boston Scientific Corporation
    • Edward Lifesciences
    • Teleflex Incorporated
    • Johnson & Johnson
    • LeMaitre Vascular, Inc.
    • Strub Medical GmbH & Co. KG
    • AngioDynamics
    • iVascular SLU
    • Cook Group Incorporated

第7章 市場機會及未來趨勢

目錄
Product Code: 67877

The key driving factors for the growth of clot management devices include increasing prevalence of cardiovascular diseases, rise in geriatric population and growing awareness which is leading to increased use of clot management devices. According to the World Health Organization (WHO), cardiovascular diseases cause 17.9 million deaths each year worldwide. Furthermore, increasing prevalence of stroke and heart attack, growing demand for minimally invasive procedures in the treatment of blood clots is expected to bolster the market growth.

In addition, advances in clot management technologies and efforts of the companies in innovating the treatments for blood clot management are further fuelling the market growth. However, stringent regulatory policies and availability of alternative treatments are expected to hamper the market growth.

Key Market Trends

Neurovascular Embolectomy is Expected to Register Significant Growth

  • Neurovascular embolectomy projected to have significant growth rate owing to increasing R&D investments and continuous innovations in product technologies.
  • Furthermore, growing demand for minimally invasive procedures coupled with rising awareness in patients regarding these treatments is expected to fuel the segment growth.
  • According to the World Health Organization (WHO), the number of people suffering from deep vein thrombosis (DVT) and pulmonary embolism (PE) is much larger than people suffering from AIDS, and Cancer. During the year 2015, around 9,00,000 people were diagnosed by DVT & PE in the United States.
  • Furthermore, rise in hip, knee and spinal surgeries which are high-risk factors for stroke are expected to boost the stroke-related catheter-directed thrombolysis market. Moreover, sedentary lifestyle and unhealthy food habits leading to obesity and other vein related diseases expected to boost the market growth over the forecast period.

North America is Expected to have Significant Market Share

North America is projected to have significant market share over the forecast period owing to favourable reimbursement policies and availability of well-established healthcare infrastructure. In addition, the burden of cardiac patients and technological advancements in devices to produce better clinical outcomes are driving the market growth in the United States. According to the Center for Disease Control (CDC), approximately, 795,000 people in the United Sstates are having stroke as of 2019. Of these, 610,000 are first or new strokes. Furthermore, stroke annually costs 34 billion in the United States alone.

The Asia Pacific region is projected to have notable growth rate over the forecast period owing to the factors such as improving healthcare infrastructure, urbanization leading to the sedentary lifestyle and growing burden of stroke in the region. Moreover, a large patient pool growing healthcare spending in the region expected to bolster the regional growth over the forecast period.

Competitive Landscape

Global clot management devices market is moderately consolidated and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in clot management devices market include Medtronic Plc, Boston Scientific Corporation, Edward Lifesciences, AngioDynamics, Inc. and LeMaitre Vascular, Inc. among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases and Ageing Population
    • 4.2.2 Growing Demand for Minimally Invasive Surgeries and Advancements in Technologies
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Procedures
    • 4.3.2 Availability of Alternative Treatments
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Embolectomy Balloon Catheter
    • 5.1.2 Catheter Directed Thrombolysis Devices
    • 5.1.3 Percutaneous Thrombectomy Devices
    • 5.1.4 Inferior Vena cava Filters
    • 5.1.5 Neurovascular Embolectomy Devices
  • 5.2 By End-User
    • 5.2.1 Hospitals
    • 5.2.2 Ambulatory Surgical Centers
    • 5.2.3 Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic Plc
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Edward Lifesciences
    • 6.1.4 Teleflex Incorporated
    • 6.1.5 Johnson & Johnson
    • 6.1.6 LeMaitre Vascular, Inc.
    • 6.1.7 Strub Medical GmbH & Co. KG
    • 6.1.8 AngioDynamics
    • 6.1.9 iVascular SLU
    • 6.1.10 Cook Group Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS